Invictus Private Wealth LLC lowered its stake in Harrow Health, Inc. (NASDAQ:HROW – Free Report) by 17.4% during the 1st quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 639,316 shares of the company’s stock after selling 134,806 shares during the period. Harrow Health makes up about 1.6% […]
Harrow Health, Inc. (NASDAQ:HROW – Get Free Report)’s share price was up 6.5% during trading on Monday . The stock traded as high as $15.89 and last traded at $15.80. Approximately 191,766 shares were traded during trading, a decline of 58% from the average daily volume of 455,751 shares. The stock had previously closed at […]
Harrow Health, Inc. (NASDAQ:HROW – Get Free Report) CEO Mark L. Baum acquired 5,800 shares of the company’s stock in a transaction that occurred on Monday, August 14th. The shares were acquired at an average price of $17.05 per share, with a total value of $98,890.00. Following the completion of the transaction, the chief executive […]
Harrow Health, Inc (NASDAQ:HROW) Director Buys $338,400 00 in Stock theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
Harrow Health, Inc. (NASDAQ:HROW – Get Free Report)’s stock price gapped up before the market opened on Tuesday following insider buying activity. The stock had previously closed at $17.28, but opened at $17.64. Harrow Health shares last traded at $17.73, with a volume of 81,425 shares trading hands. Specifically, CEO Mark L. Baum acquired 5,800 […]